≥99%
170851-70-4
711.85 g/mol
Researchers studying Ipamorelin often combine
Save $120 with the Tesamorelin + Ipamorelin Blend
All 2 compounds in a single lyophilized vial. Pre-blended at researcher-validated ratios for in-vitro co-incubation studies — no separate reconstitutions to manage.
Buying singles
- Tesamorelin 10mg$130
- Ipamorelin 5mg$90
Tesamorelin + Ipamorelin Blend
10mg (5mg/5mg)
Ipamorelin
Ipamorelin is a 5-amino acid synthetic peptide growth hormone secretagogue supplied for in-vitro GHS-R1a receptor-binding assays and selectivity profiling.
1 vial × $90 each
Add 3+ to unlock
volume pricing
Pay by Zelle or PayPal · no processing fees · ships once payment clears
Free US shipping on orders over $200, with tracking provided.
Third-party tested
Supplied to qualified labs and institutional buyers. Institutional use & buyer eligibility
Characteristics
| Property | Value |
|---|---|
| Molecular Formula | C₃₈H₄₉N₉O₅ |
| CAS Number | 170851-70-4 |
| Molar Mass | 711.85 g/mol |
| Amino Acid Sequence | Aib-His-D-2-Nal-D-Phe-Lys-NHâ‚‚ (pentapeptide) |
| Synonyms | NNC 26-0161, Ipamorelin acetate |
| Physical Form | Lyophilized powder |
| Solubility | Soluble in water and aqueous laboratory solvent |
| Organoleptic Profile | White lyophilized powder; odorless |
| Storage Conditions | Store lyophilized at -20°C; reconstituted solution stable at 2-8°C for up to 21 days |
| Composition | Lyophilized ipamorelin acetate salt |
How is Ipamorelin Used in Research?
Ipamorelin is a 5-amino acid synthetic pentapeptide growth hormone secretagogue supplied as a lyophilized reference standard for in-vitro GHS-R1a (ghrelin receptor) binding assays and selectivity profiling. The compound is characterized in laboratory workflows as a high-selectivity GHS-R1a ligand; in-vitro binding assays profile its affinity relative to broader-spectrum GHS reference compounds such as GHRP-6 and GHRP-2.
At the molecular level, ipamorelin is studied in recombinant GHS-R1a expression systems and cultured pituitary somatotroph cell lines. Binding activates phospholipase C through Gq/11-protein coupling; standard laboratory readouts include IP1/IP3 accumulation assays and intracellular calcium-flux assays. The pentapeptide's selectivity is profiled in parallel panels against cortisol, ACTH, prolactin, FSH, LH, and TSH receptor systems — making it a useful reference tool for receptor-selectivity characterization.
Researchers use ipamorelin as a reference standard in analytical method development (HPLC identity and purity assays, LC-MS mass-accuracy work) and as a GHS-R1a reference ligand for comparability testing of novel secretagogue analogs. Not for use in any living organism.
This product is supplied in a lyophilized form and requires reconstitution prior to laboratory handling. For research and laboratory use only. Not for human or veterinary consumption.
Areas of Study
In-Vitro GHS-R1a Binding Assays
Applied as a reference ligand in competitive binding and functional (IP1, calcium-flux) assays on recombinant GHS-R1a cell systems.
Receptor Selectivity Profiling
Used in multi-receptor panels to characterize selectivity versus cortisol, ACTH, prolactin, FSH, LH, and TSH receptor systems.
Analytical Method Development
Serves as an identity and purity reference standard in HPLC, LC-MS, and comparability work against novel GHS analogs.
Structural Characterization
Characterized by mass spectrometry and circular dichroism to confirm sequence identity and secondary-structure content of the pentapeptide.
Combination Receptor Studies
Used alongside GHRH-receptor reference ligands such as CJC-1295 no DAC in two-receptor in-vitro co-activation studies.
References
- [1]Raun K, Hansen BS, Johansen NL, et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 139(5), 552-561.
- [2]Johansen PB, Nowak J, Skjaerbaek C, et al. (1999). Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Hormone & IGF Research, 9(2), 106-113.
- [3]Anderson LL, Jeftinija S, Scanes CG, et al. (2004). Physiology of ghrelin and related peptides. Domestic Animal Endocrinology, 29(1), 111-144.
Disclaimer: The information provided is for research reference only and does not constitute medical advice. Products are sold strictly for in-vitro research use.
Certificate of Analysis (COA)
Third-Party Verified Quality
Every batch of Ipamorelinis independently tested by an A2LA-accredited (ISO 17025:2017) third-party laboratory using HPLC-UV/VIS for purity and measured quantity. Each COA carries the lab's signed report and a batch-specific lot number. We publish these results publicly so you can verify exactly what you're getting.
View Lab ResultsRelated Products
GLP3R
10mg – 60mg
Triple-agonist research peptide targeting GIP, GLP-1, and glucagon receptors in preclinical metabolic studies.
Ipamorelin 5mg + Mod GRF 1-29 (Blend)
5mg
Modified GRF 5mg, Ipamorelin 5mg (10mg Total Blend) {Modified GRF 5mg is the same substance also knows of CJC-1295 5mg (No DAC)} Modified GRF 5mg (or CJC-1295) causes the natural release of GH, but it does so by naturally stimulating the...
CJC-1295 no DAC (Mod GRF 1-29)
1 vial
CJC-1295 (no DAC) (Modified GRF) is a truncated peptide analogue of growth hormone releasing hormone (GHRH). First developed in the 1980s, research studies with modGRF have shown it to improve muscle repair and growth, accelerate wound...
CJC-1295 (no DAC), Ipamorelin 10mg (Blend)
10mg
CJC-1295 5mg (No DAC), Ipamorelin 5mg (10mg Total Peptide Blend) CJC-1295 causes the natural release of GH, but it does so by naturally stimulating the growth hormone releasing hormone receptor. Ipamorelin is one of the most selective...
Frequently Bought Together
Ipamorelin
5mg
$90
GLP3R
10mg
$180
Ipamorelin 5mg + Mod GRF 1-29 (Blend)
5mg
$125
Bundle total
$395